GSK offers 40pc premium in US$10.6b bid for cancer drug developer Nuvalent
Deal values cancer drug developer Nuvalent at US$124 (RM503) per shareThat is a 40 per cent premium to the US-listed fir...
Malay Mail · "OFFERS" · 총 7건
필터 보기현재 지수
48.5
0 = 부정 우세
50 = 중립
100 = 긍정 우세
최근 7일 기준 802건을 분석한 결과, 뉴스 심리지수는 48.5(균형)입니다. 긍정 73건(9.1%)·중립 567건(70.7%)·부정 162건(20.2%)이며, 중립 비중이 뚜렷하게 높습니다. 성향 지수는 종합 100.0(강한 보수 경향)입니다.
Deal values cancer drug developer Nuvalent at US$124 (RM503) per shareThat is a 40 per cent premium to the US-listed fir...
KUALA LUMPUR, June 8 — A Singaporean artist who uses a power-washer to turn dirt-streaked surfaces into public art...
PENDANG, June 5 — Visitors can pick their own premium-grade Chokanan mangoes at RM6 per kilogramme at the 2026 Tob...
JUNE 1 — Malaysia’s agriculture sector faces a dual challenge: an ageing farming population and declining yo...
KOTA BHARU, May 30 — The Kelantan Health Department will conduct a further investigation and improve operating pro...
BUENOS AIRES, May 27 — Argentina coach Lionel Scaloni said the initial news regarding superstar Lionel Messi&rsquo...
ISTANBUL, May 25 — The Defence Ministry (Mindef) is evaluating offers from several countries to find the best solu...